Comparison of glyburide and insulin in women with gestational diabetes mellitus and associated perinatal outcome: A randomized clinical trial

Acta Medica Iranica

Volumn 53, Issue 2, 2015, Pages 97-103

  Mirzamoradi, Masoomeh ^a   Heidar, Zahra ^a   Faalpoor, Ziba ^a   Naeiji, Zahra ^a   Jamali, Razyeh ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Gestational Diabetes Mellitus; Glyburide; Insulin; Treatment

Indexed keywords

GLIBENCLAMIDE; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BIRTH WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS OUTCOME; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; HYPERBILIRUBINEMIA; HYPOCALCEMIA; HYPOGLYCEMIA; MACROSOMIA; MAJOR CLINICAL STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PERINATAL PERIOD; POLYCYTHEMIA; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TRANSIENT TACHYPNEA OF THE NEWBORN; TREATMENT OUTCOME; ADOLESCENT; CHEMICALLY INDUCED; DIABETES, GESTATIONAL; DRUG EFFECTS; MIDDLE AGED; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INSULIN; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; YOUNG ADULT;

EID: 84923607428     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wendland EM, Torloni MR, Falavigna M, et al. Gestational diabetes and pregnancy outcomes:a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth 2012;12(1):23.
2. DeSisto CL, Kim SY, Sharma AJ. Prevalence Estimates of Gestational Diabetes Mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010. Prev Chronic Dis 2014;11:E104.
3. Ferrara A. Increasing Prevalence of Gestational Diabetes Mellitus: A public health perspective. Diabetes Care 2007;30(Suppl 2):S141-6.
4. Cundy T, Ackermann E, Ryan EA. Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear. BMJ 2014;348:g1567.
5. Yogev Y, Ben-Haroush A, Chen R, et al. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol 2004;104(1):88-93.
6. Moore TR. Glyburide for the Treatment of Gestational Diabetes: A critical appraisal. Diabetes Care 2007;30(Suppl 2):S209-3.
7. Langer OD, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes. N Engl J Med 2000;343(16):1134-38.
8. Gabbe SG, Gregory RP, Power ML, et al. Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol 1998;91(5 Pt 1):643-7.
9. Corbet A, Bucciarelli R, Goldman S, et al. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. J Pediatr 1991;118(2):277-84.
10. Magdy MA, Allam A, Mostafa AA, et al. Oral Hypoglycemic as Attractive Alternative to Insulin for the Management of Diabetes Mellitus during Pregnancy. Gynecol Obstet (Sunnyvale) 2014;4:193.
11. Elliott BD, Langer O, Schenker S, et al. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 1991;165(4 Pt 1):807-12.
12. Garcia Bournissen F, Feig DS, Koren G. Maternal-fetal transport of hypoglycaemic drugs. Clin Pharmacokinet 2003;42(4):303-13.
13. Anjalakshi C, Balaji V, Balaji S, et al. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in asian Indian woman. Diabetes Res Clin Pract 2007;76(3):474-5.
14. Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol 2004;190(5):1438-9.
15. Chmait R, Dinise T, Moore T. Prospective observational study to establish predictors of the glyburide success in women with gestational diabetes mellitus. J Perinatol 2000;24(10):617-22.
16. Jacobson GF, Ramos GA, Ching JY, et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 2005;193(1):118-24
17. Kimber-Trojnar Z, Marciniak B, Leszczynska-Gorzelak B, et al. Glyburide for the treatment of gestational diabetes mellitus. Pharmacol Rep 2008;60(3):308-18.
18. Conway DL, Gonzales O, Skiver D. Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. J Matern Fetal Neonat Med 2004;15(1):51-5.
19. Fines V, Moore T, Castle S. A Comparison of Glyburide and Insulin Treatment in Gestational Diabetes Mellitus on Infant Birth Weight and Adiposity. 189(6):S108.
20. Holt RI, Goddard JR, Clarke P, et al. Apost natal fasting plasma glucose in useful in determining which women with gestational diabetes should undergo a postnatal oral glucose tolerance. Diabet Med 2003;20(7):594-8.
21. Moretti ME, Rezvani M, Koren G. Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes. Ann Pharmacother 2008;42(4):483-90.